The expanding class of drugs known as GLP-1 receptor stimulators are impacting diabetes management , but the route of administration is emerging as a key consideration . Previously, these beneficial medications were available solely in tablet form. However, new patches are now becoming accessible , leading to many patients to ask which option is be